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INTRODUCTION
The incidence of primary mucinous adenocarcinoma is
low. Many previously diagnosed cases are now retrospective-
ly regarded as metastatic mucinous adenocarcinomas or bor-
derline mucinous tumors. Primary mucinous adenocarcino-
ma is characterized by a large unilateral ovarian mass with a
smooth external surface. Young age, an expansile growth
pattern, a complex papillary pattern, necrotic luminal debris,
and histologic areas resembling benign and borderline muci-
nous tumors are characteristic of primary mucinous adenocar-
cinoma. Metastatic mucinous adenocarcinoma is more like-
ly bilateral and shows a multinodular external surface. The
cut surface of the metastatic lesion varies from completely
solid to multicystic, mimicking the primary ovary mass. Find-
ings of ovarian capsular implants, vascular invasion, a nodu-
lar growth pattern, and infiltrative growth of individual glands
or single cells on microscopic examination favor metastasis
(1-5). The most important and helpful finding to differenti-
ate metastatic from primary cancers is knowledge of the clini-
cal history of a primary malignancy. 
Seidman et al. proposed an algorithm based on tumor size
and laterality in which unilateral ≥10 cm were considered
as primary mucinous and all others as metastatic. This algo-
rithm correctly classified mucinous adenocarcinomas in 84%
of all 194 cases, including 100% of primary origin tumors
and 77% of all metastatic tumors (4). By adjusting the size
criterion to 13 cm, the performance of the algorithm was im-
proved with correct classification of 87% of tumors, includ-
ing 98% of primary tumors and 82% of metastatic tumors (6). 
In Korea, ovarian malignancy is the 9th in frequency with
annual incidence of 1,300 cases (7). Primary mucinous ade-
nocarcinoma of the ovary is diagnosed in less than 10% of
ovarian malignancies (8). Intraoperative distinction between
primary and metastatic mucinous adenocarcinomas on frozen
sections is challenging and has potential for misdiagnosis (9).
For intraoperative consultation of mucinous adenocarcino-
ma involving the ovary, it is useful to have additional meth-
ods other than the limited traditional microscopic findings
to determine the nature of the ovarian mucinous tumors.
Because ovarian mucinous tumors are rarely encountered and
notorious for difficulty in distinction between primary and
metastatic tumors. Herein, we have re-evaluated the useful-
ness of the simple algorithm using the size and laterality cri-
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Mucinous Adenocarcinoma Involving the Ovary: Comparative Evaluation
of the Classification Algorithms using Tumor Size and Laterality
For intraoperative consultation of mucinous adenocarcinoma involving the ovary, it
would be useful to have approaching methods in addition to the traditional limited
microscopic findings in order to determine the nature of the tumors. Mucinous ade-
nocarcinomas involving the ovaries were evaluated in 91 cases of metastatic muci-
nous adenocarcinomas and 19 cases of primary mucinous adenocarcinomas using
both an original algorithm (unilateral ≥10 cm tumors were considered primary and
unilateral <10 cm tumors or bilateral tumors were considered metastatic) and a mod-
ified cut-off size algorithm. With 10 cm, 13 cm, and 15 cm size cut-offs, the algorithm
correctly classified primary and metastatic tumors in 82.7%, 87.3%, and 89.1% of
cases and in 80.6%, 84.9%, and 87.1% of signet ring cell carcinoma (SRC) exclud-
ed cases. In total cases and SRC excluded cases, 98.0% and 97.2% of bilateral
tumors were metastatic and 100% and 100% of unilateral tumors <10 cm were
metastatic, respectively. In total cases and SRC excluded cases, 68.4% and 68.4%
of unilateral tumors ≥15 cm were primary, respectively. The diagnostic algorithm
using size and laterality, in addition to clinical history, preoperative image findings,
and operative findings, is a useful adjunct tool for differentiation of metastatic muci-
nous adenocarcinomas from primary mucinous adenocarcinomas of the ovary. 
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terion with 10 cm, 13 cm, and 15 cm cut-off values, for dif-
ferentiation of primary mucinous adenocarcinoma from meta-
static mucinous adenocarcinoma.
MATERIALS AND METHODS
Cases which were diagnosed as either primary mucinous
adenocarcinoma or metastatic adenocarcinoma with muci-
nous differentiation from 1996 January to 2005 December
were retrieved from archives at Catholic University of Korea,
Kangnam St. Mary’s Hospital and St. Mary’s Hospital. All
slides were reviewed and reclassified according to the 2003
WHO classification. Metastatic adenocarcinoma with more
than focal mucin production was classified as metastatic ade-
nocarcinoma with mucinous differentiation. Metastatic muci-
nous adenocarcinoma with an unknown primary site, bor-
derline mucinous tumors, and microinvasive mucinous ade-
nocarinomas were excluded. Clinicopathologic data regard-
ing age, tumor size, laterality, and follow up data were col-
lected. Clinicopathologic data from most metastatic tumors
were reported previously (10). 
We used a simple algorithm using size and laterality cri-
teria that classified all bilateral mucinous carcinomas as meta-
static, unilateral mucinous carcinomas <10 cm as metastat-
ic, and unilateral mucinous carcinoma ≥10 cm as primary.
We also used a modified algorithm with size cut-offs of 13
cm and 15 cm. Results using the different algorithms were
compared with the final diagnosis in each case. Overall sur-
vival (OS) was defined as the date from the time of the first
diagnosis of ovarian malignancy to death from any cause, or
to the date of last contact. 
Analyses of overall survival were performed using Kaplan-
Meier survival curves. All eligible patients were included in
the analyses of OS and all causes of death were included in
the calculation of survival. 
RESULTS
Clinical characteristics
A total of 91 cases of metastatic mucinous adenocarcino-
ma and 19 cases of primary mucinous adenocarcinoma from
1996 to 2006 were included in this study to evaluate the algo-
rithm using the size and laterality criteria. The mean age of
patients with metastatic mucinous adenocarcinoma was 47
yr (median 45, range 19-76) and the mean age of patients
with primary mucinous adenocarcinoma was 42 yr (median
40, range 16-71). All primary mucinous adenocarcinomas
were surgically staged, except for one case. Stages included
stage I in 12 cases, stage III in 5 cases, and stage IV in 1 case.
Metastatic mucinous adenocarcinoma cases included those
from the colorectum in 46 cases, stomach in 34 cases, gallblad-
der in 4 cases, breast in 2 cases, lung in 2 cases, vermiform
appendix in 2 cases, and uterine cervix in 1 case. Among meta-
static mucinous adenocarcinomas, 17 cases (18.7%) showed
more than 50% of signet ring cell differentiation. These 17
cases of signet ring cell carcinoma (SRC) included 13 cases
from the stomach and 4 cases from the colorectum. 
Size and laterality
Primary mucinous adenocarcinomas were unilateral in
94.7% (18/19) of cases. Metastatic mucinous adenocarcino-
mas were bilateral in 54.9% (50/91) of cases. Primary muci-
nous adenocarcinomas had a mean size of 18.2 cm (range, 11-
30) and metastatic mucinous adenocarcinomas had a mean
size of 10.3 cm (range, 1.8-22). 
The distribution of primary and metastatic mucinous ade-
nocarcinomas classified by tumor size (10 cm, 13 cm, and
15 cm of cut-off values) and laterality (unilateral and bilat-
eral) is shown in Table 1. With the 10 cm size cut-off, the
algorithm correctly classified primary vs. metastatic muci-
nous adenocarcinoma in 82.7% of cases (91/110), including
All tumors
≥10 cm <10 cm No. ≥13 cm <13 cm ≥15 cm <15 cm
Tumors excluding signet ring cell carcinoma
≥10 cm <10 cm No. ≥13 cm <13 cm ≥15 cm <15 cm
Unilateral
Primary  18 0 18    3  15  5  13  18 0  18  3  15  5  13 
(0%) (50%) (8.8%) (60%) (12.5%) (68.4%) (0%) (50%) (8.8%) (60%) (12.5%) (68.4%)
Metastatic 41 23  18  31  10  35  6  39 22  17  29  10 33  6 
(100%) (50%) (91.2%) (40%) (87.5%) (31.6%) (100%) (48.6%) (90.6%) (40%) (86.8%) (31.6%)
Bilateral
Primary 1 0 1 0 1 0  1  1 0 1  0 1 0  1 
(0%) (3.3%) (0%) (5%) (0%) (5.9%) (0%) (4.5%) (0%) (6.3%) (0%) (6.7%)
Metastatic 50 21  29  31  19  34  16  35 14  21  20  15  21  14 
(100%) (96.7%) (100%) (95%) (100%) (94.1%) (100%) (95.5%) (100%) (93.7%) (100%) (93.3%)
% of correctly  82.7 87.3 89.1 80.6 84.9 87.1
classified
Table 1. Distribution of primary/metastatic mucinous adenocarcinomas based on size with 10 cm, 13 cm, and 15 cm cut off, respec-
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94.7% for primary and 80.2% for metastatic. With the 13
cm size cut-off, the algorithm correctly classified primary vs.
metastatic in 87.3% of cases (96/110), including 78.9% for
primary and 89.0% for metastatic. With the 15 cm size cut-
off, the algorithm correctly classified primary vs. metastatic
in 89.1% of cases (98/110), including 68.4% for primary and
93.4% for metastatic (Tables 1, 2). Of 74 mucinous adenocar-
cinomas with a size of <10 cm or with bilateral involvement,
73 cases (98.6%) were metastatic. Of 19 mucinous adenocar-
cinomas with a size of ≥15 cm and unilateral involvement,
13 cases (68.4%) were primary. Of 17 mucinous adenocar-
cinomas with a size between 10 cm and 15 cm and unilat-
eral involvement, 5 cases (29.4%) were primary and 12 cases
(70.6%) were metastatic (Table 3). We also evaluated these
algorithms with ovarian mucinous adenocarcinoma exclud-
ing SRC, since SRC has characteristic histologic findings that
can be easily diagnosed. With the 10 cm size cut-off, the algo-
rithm correctly classified primary vs. metastatic mucinous
adenocarcinoma in 80.6% of cases (75/93), including 94.7%
for primary and 77.0% for metastatic. With the 13 cm size
cut-off, the algorithm correctly classified primary vs. metastat-
ic in 84.9% of cases (79/93), including 78.9% for primary
and 86.5% for metastatic. With the 15 cm size cut-off, the
algorithm correctly classified primary vs. metastatic in 87.1%
of cases (81/93), including 68.4% for primary and 91.9% for
metastatic (Tables 1, 2). Of 58 mucinous adenocarcinomas
with a size of <10 cm or with bilateral involvement, 57 cases
(98.3%) were metastatic. Of 19 mucinous adenocarcinomas
All tumors
No. size 10 to <15 cm size <10 cm size ≥15 cm
Tumors excluding signet ring cell carcinoma
No. size 10 to <15 cm size <10 cm size ≥15 cm
Unilateral
Primary  18 0 (0%) 5 (29.4%) 13 (68.4%) 18 0 (0%) 5 (31.3%) 13 (68.4%)
Metastatic 41 23 (100%) 12 (70.6%) 6 (31.6%) 39 22 (100%) 11 (68.7%) 6 (31.6%)
Total 59 23 (100%) 17 (100%) 19 (100%) 57 22 (100%) 16 (100%) 19 (100%)
Bilateral
Primary  1 0 (0%) 0 1 (5.9%) 1 0 (0%) 0 1 (6.7%)
Metastatic  50 21 (100%) 13 (100%) 16 (94.1%) 35 14 (100%) 7 (100%) 14 (93.3%)
Total 52 22 (100%) 13 (100%) 17 (100%) 37 15 (100%) 7 (100%) 15 (100%)
Table 3. Distribution of primary/metastatic mucinous adenocarcinomas classified by size <10 cm, 10 to <15 cm and ≥15 cm, and
laterality
All tumors
No.
Tumor origin
Mean
size
(range)
(cm)
Bilater-
ality
Cases of correctly 
classified with
10 cm
cut-off
13 cm
cut-off
15 cm
cut-off
Tumors excluding signet ring cell carcinoma
No.
Mean
size
(range)
(cm)
Bilater-
ality
Cases of correctly 
classified with
10 cm
cut-off
13 cm
cut-off
15 cm
cut-off
Primary ovary tumor 19 18.2 1 18 15 13 19 18.2 1 18 15 13
(11-30) (5.3%) (94.7%) (78.9%) (68.4%) (11-30) (5.3%) (94.7%) (78.9%) (68.4%)
Metastatic tumor 91 10.3 50 73 81 85 74 10.1 35 57 64 68
(1.8-22) (54.9%) (80.2%) (89.0%) (93.4%) (1.8-21) (47.3%) (77.0%) (86.5%) (91.9%)
Colorectum 46 10.7 20 33 40 42  42 10.5 17  30 36 38 
(2-22) (43.5%) (71.7%) (87%) (91.3%) (2-21) (40.5%) (71..4%) (85.7%) (90.5%)
Stomach 34 9.95 24 31 32 32  21 10.2  12 18 19 19
(1.8-20) (70.6%) (91.2%) (94.1%) (94.1%) (1.8-20) (57.1%) (85.7%) (90.5%) (90.5%)
Gallbladder 4 11.8 2 3 3 4 4 11.8 2 3  3 4
(6-21) (50%) (75%) (75%) (100%) (6-21) (50%) (75%) (75%) (100%)
Breast 2 8.25 1 1 1 2 2 8.25 1 1 1 2
(2.5-14) (50%) (50%) (50%) (100%) (2.5-14) 1 (50%) 1 (50%) 1 (50%) (100%)
Lung 2 12 2 2 2 2 2 12 2 2 2 2
(10-14) (100%) (100%) (100%) (100%) (10-14) (100%) (100%) (100%) (100%)
Vermiform appendix 2 5.3 1 2 2 2 2 5.3 1 2  2 2
(4.5-6) (50%) (100%) (100%) (100%) (4.5-6) (50%) (100%) (100%) (100%)
Uterine cervix 1 4.5 0  1 1 1 1 4.5 0 1 1 1
(4.5-4.5) (0%) (100%) (100%) (100%) (4.5-4.5) (0%) (100%) (100%) (100%)
Table 2. Performance of the algorithm (size of 10 cm cut off and laterality) and modified algorithms (size of 13 cm and 15 cm cut off,
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with a size of ≥15 cm and unilateral involvement, 13 cases
(68.4%) were primary. Of 16 mucinous adenocarcinomas with
a size between 10 cm and 15 cm and unilateral involvement,
5 cases (31.3%) were primary and 11 cases (68.7%) were meta-
static (Table 3).
Survival
With a median follow-up period of 11 months (range, 1-
122), 73 out of 110 (66.4%) patients died. Of 19 patients
with primary mucinous adenocarcinoma, 17 patients were
treated with surgery and adjuvant chemotherapy and two
patients were treated with surgery only. The 5-yr overall sur-
vival rates were 87% for primary mucinous adenocarcinoma
and 6% for metastatic mucinous adenocarcinoma (Fig. 1).
DISCUSSION
Mucinous adenocarcinomas of the ovary are usually large,
unilateral, smooth surfaced, multilocular or unilocular cystic
masses containing watery or viscous mucoid materal. They
are bilateral in 5% of cases (2, 11, 12). The proportion of pri-
mary mucinous adenocarcinoma in primary ovarian epithe-
lial tumors has been recently reported as 2.4-6.7% (4, 13),
which is lower than the previously reported proportion of pri-
mary mucinous adenocarcinoma (mean 12%, range 6-25%)
(4). The low frequency of primary mucinous adenocarcinoma
can be related to a wide variety in the appearance of metastatic
mucinous adenocarcinomas of the ovaries. It has been recently
recognized that many metastatic carcinomas have been mis-
classified as primary. Some mucinous tumors that would have
been diagnosed as mucinous adenocarcinomas are diagnosed
as intraepithelial and microinvasive mucinous carcinomas
and are categorized as mucinous borderline tumors. Pseu-
domyxoma peritonei involving ovaries are known to be of
gastrointestinal origin (not ovarian) (4). 
The prognosis and treatment modalities of primary muci-
nous adenocarcinomas and metastatic mucinous adenocarci-
nomas are quite different and an accurate diagnosis is essen-
tial for an effective treatment. Because areas of malignancy
may be limited, a generous sampling of all mucinous cystic
tumors to include up to one histologic section per 1-2 cm of
tumor diameter has been recommended to make a diagnosis
(14). Sometimes, immunohistochemical staining for CK7,
CK20, CDX2, and Dpc4 are helpful to differentiate metas-
tatic from primary tumors (15-17). However, at the time of
intraoperative consultation, it is not practical to examine mul-
tiple sections or to perform immunohistochemical staining.
Therefore, a simple algorithm is useful that correctly classi-
fies a high proportion of cases on the basis of easily assessible
gross features (4). 
A performance evaluation of the algorithm to distinguish
primary from metastatic tumors using originally proposed
criteria (bilateral tumors of any size, or unilateral tumor <10
cm=metastatic; unilateral tumor ≥10 cm=primary) demon-
strated excellent diagnostic performance. Overall, 84-90%
of all tumors were correctly classified (4, 6, 13). Using the
same criteria, we found that 91 out of 110 cases (82.7%) were
correctly classified. In the subgroup of unilateral tumors ≥10
cm, the proportion of primary mucinous adenocarcinomas
varied from 62% to 82% (4, 13). This discrepancy reflects
differences in metastatic ovarian tumor sizes between the study
populations. Delay prior to visiting hospital for detection of
ovarian metastasis leads to larger sized tumors (13). 
In our subgroup of unilateral tumors ≥10 cm, the propor-
tion of primary mucinous adenocarcinomas was only 50%.
By adjusting the size criterion to 13 cm, and 15 cm, 87.3%
(96 out of 110 cases) and 89.1% (98 out of 110 cases) of cases,
respectively, were correctly classified. In the unilateral tumor
subgroup with cut-off values of ≥13 cm and ≥15 cm, the
proportion of primary mucinous adenocarcinoma increased to
60% and 68.4%, respectively. In Korea, gastric cancer meta-
stasis to the ovary is common. Many cases show characteris-
tic signet ring cell features of which diagnosis is easily made.
Therefore we evaluated mucinous adenocarcinoma excluding
SRC using the algorithms with cut-offs of 10 cm, 13 cm, and
15 cm. The results revealed similar trends with the results
of total cases (Tables 1-3).
Using the algorithm with a size cut off of 15 cm, 89.1%
and 87.1% of total cases and SRC excluded cases were cor-
rectly classified respectively. All unilateral tumors <10 cm
were metastatic but unilateral tumor sizes of 10 cm to <15
cm were metastatic in 70.6% and 68.7% of total cases and
SRC excluded cases, respectively. This result supports the
need for the modification suggested by Khunamornpong et
al. (13) (all bilateral tumors or unilateral tumors <10 cm are
metastatic, unilateral tumors ≥15 cm are primary, and uni-
lateral tumors with sizes between 10 cm and 15 cm are inde-
terminate). Application of this modified algorithm resulted
Fig. 1. Overall survival curves of primary and metastatic mucinous
adenocarcinomas.
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in correct classification of 86 out of 93 cases (92.5%) and 70
out of 77 cases (90.9%), respectively, and 17 cases (15.5%)
and 16 cases (17.2%) remained undetermined. Misclassified
cases included 1 case of bilateral primary mucinous adeno-
carcinoma and 6 cases of ≥15 cm unilateral metastatic muci-
nous adenocarcinomas (4 from the colorectum and 2 from
the stomach). Among 6 misclassified and 12 indeterminat-
ed metastatic tumors, primary malignancies were detected
ahead of an ovarian mass in 5 cases and synchronously with
an ovarian mass in 12 cases (Table 4). According to these data,
a complete clinical history and a careful search for possible
primary tumors in the operation field, especially in the gas-
trointestinal tract, is important. When surgeons submit intra-
operative frozen samples for examination, they should pro-
vide pathologists a clinical history and intraoperative find-
ings, such as the status of the opposite ovary. 
In conclusion, an algorithm using size and laterality is a
useful adjunct tool for differentiation of metastatic mucinous
adenocarcinoma from primary mucinous adenocarcinoma of
the ovary. However, clinicopathologic evaluation is impor-
tant, especially when the tumor is unilateral with a size bet-
ween 10 cm and 15 cm. 
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